Keryx

Spotlight on Anadys, Keryx as biotechs' shares trade higher
MarketWatch
Sat, 05/22/10 - 09:39 am
Anadys
Keryx
biotech
ASCO's Abstract Release Day: Preview
TheStreet.com
Wed, 05/19/10 - 07:09 pm
oncology
cancer
ASCO
Celldex
Keryx
Delcath
Sunesis
Ziopharm
Pharmacyclics
OncoGenex
Keryx Biopharmaceuticals Could Easily Triple Within the Next Year
Seeking Alpha
Mon, 04/12/10 - 09:04 am
Dendreon
Keryx
Merck
Pfizer
Ranbaxy
Sanofi
Keryx, AEterna Zentaris announce trial start for cancer drug perifosine
Yahoo/AP
Thu, 04/8/10 - 02:25 pm
Keryx
Aeterna Zentaris
clinical trials
perifosine
colorectal cancer
Drug Pipeline Pulse Check: Teva on a Tear
Seeking Alpha
Tue, 04/6/10 - 03:53 pm
Teva Pharmaceuticals
Abbott Laboratories
Amag Pharmaceuticals
AstraZeneca
Aeterna Zentaris
Cubist Pharmaceuticals
Keryx
KV Pharmaceutical
Eli Lilly
Novartis
Savient
Sanofi
Keryx, Aeterna rocket on FDA move
Marketwatch
Mon, 04/5/10 - 07:03 pm
Aeterna Zentaris
Keryx
FDA
perifosine
colorectal cancer
Keryx's Loss Wider than Expected
Yahoo/Zacks
Sat, 03/27/10 - 11:19 am
Keryx
Biotech Stock Mailbag: NexMed
TheStreet.com
Fri, 02/12/10 - 08:20 am
NexMed
Sequenom
Vivus
Keryx
Targacept
Immunogen
Cell Therapeutics
Keryx Biopharmaceuticals (NASDAQ: KERX) Responds to Erroneous Report About Planned Phase III Study for Patients With Colorectal Cancer
Yahoo/MarketWire
Sat, 02/6/10 - 12:24 pm
Keryx
perifosine
colorectal cancer
Keryx Biopharma, FDA agree on design of late-stage trial for drug against colorectal cancer
Yahoo/AP
Wed, 02/3/10 - 04:08 pm
colorectal cancer
FDA
clinical trials
Keryx
perifosine
Keryx Biopharmaceuticals Announces Positive Phase 2 Study Results Of Perifosine As A Single Agent For The Treatment Of Waldenstrom's Macroglobulinemia
Medical News Today
Sat, 01/30/10 - 12:15 pm
Keryx
Waldenstrom's Macroglobulinemia
Keryx Biopharmaceuticals, AEterna Zentaris report positive perifosine study data
Yahoo/AP
Fri, 01/29/10 - 11:01 am
perifosine
Keryx
Aeterna Zentaris
cancer
Keryx and AEterna Zentaris say perifosine improved survival compared to potential competitor
Yahoo/AP
Mon, 01/25/10 - 03:57 pm
Aeterna Zentaris
Keryx
cancer
perifosine
Keryx Biopharma: A Well-Capitalized Comeback Story with Multiple Catalysts
Seeking Alpha
Sun, 01/10/10 - 11:31 am
Keryx
Biotech's Movers and Shakers 2009: BioBuzz
TheStreet.com
Mon, 01/4/10 - 09:38 am
Biogen Idec
Genzyme
Amgen
Gilead Sciences
Celgene
Vanda
Human Genome Sciences
Keryx
Opexa
CompuGen
Repros Therapeutics
Sequenom
GTx
GTC Biotherapeutics
Generic Drugs Continue To Accelerate Market Share Expansion According To Sanford Bernstein
Yahoo/Wall Street Transcript
Mon, 12/7/09 - 12:26 pm
generics
Impax Labs
Keryx
Rigel
Keryx Biopharmaceuticals cancer drug candidate gets faster regulatory review by FDA
Yahoo/AP
Wed, 12/2/09 - 10:03 am
FDA
Keryx
perifosine
cancer
13 Biotechs to Watch for at Hematology Conference
Seeking Alpha
Mon, 11/30/09 - 09:32 am
hematology
Allos
ONYX Pharmaceuticals
Facet Biotech
Seattle Genetics
Gentium
Immunogen
Cyclacel
Sunesis
Trubion
Pharmacyclics
Keryx
Aeterna Zentaris
Ariad Pharmaceuticals
Keryx Biopharmaceuticals' Next Price Movers Will Be Trial News
Seeking Alpha
Tue, 10/27/09 - 08:14 am
Keryx
Biotechs Back From The Dead
Forbes
Fri, 10/16/09 - 08:25 am
Human Genome Sciences
Vanda
Jazz Pharmaceuticals
biotech
Vermillion
Keryx
Ista
Helicos
Biocryst
Antigenics

Pages